Literature DB >> 22514462

Treatment of cytomegalovirus retinitis: A growing number of options.

S D Shafran1, J M Conly.   

Abstract

Entities:  

Year:  1996        PMID： 22514462      PMCID： PMC3327430          DOI： 10.1155/1996/681741

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  23 in total

1.  Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.

Authors:  W G Hodge; R G Lalonde; J Sampalis; J Deschênes
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.

Authors:  F M Rahhal; J F Arevalo; E Chavez de la Paz; D Munguia; S P Azen; W R Freeman
Journal:  Ann Intern Med       Date:  1996-07-15       Impact factor: 25.391

Review 3.  Cidofovir.

Authors:  A P Lea; H M Bryson
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

4.  Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.

Authors:  M Díaz-Llopis; E Chipont; S Sanchez; E España; A Navea; J L Menezo
Journal:  Am J Ophthalmol       Date:  1992-12-15       Impact factor: 5.258

5.  Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region.

Authors:  R F Azad; V B Driver; K Tanaka; R M Crooke; K P Anderson
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

6.  A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group.

Authors:  S A Spector; T Weingeist; R B Pollard; D T Dieterich; T Samo; C A Benson; D F Busch; W R Freeman; P Montague; H J Kaplan
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

7.  Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.

Authors:  B D Kuppermann; J G Petty; D D Richman; W C Mathews; S C Fullerton; L S Rickman; W R Freeman
Journal:  Am J Ophthalmol       Date:  1993-05-15       Impact factor: 5.258

8.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

Authors:  D F Martin; D J Parks; S D Mellow; F L Ferris; R C Walton; N A Remaley; E Y Chew; P Ashton; M D Davis; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1994-12

9.  Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome.

Authors:  G N Holland; M S Gottlieb; R D Yee; H M Schanker; T H Pettit
Journal:  Am J Ophthalmol       Date:  1982-04       Impact factor: 5.258

10.  Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-01
View more
  3 in total

Review 1.  Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.

Authors:  C M Perry; R Davis
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

2.  Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.

Authors:  Ifeoma N Ude; Steven Yeh; Jessica G Shantha
Journal:  Ann Eye Sci       Date:  2022-03

3.  Combined Cytomegalovirus and Herpes Simplex Virus-related Neuroretinitis in an Immunocompetent Patient.

Authors:  Suntaree Thitiwichienlert; Supinda Leeamornsiri
Journal:  Korean J Ophthalmol       Date:  2019-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.